Bacterial Disease Diagnostics Market Size & Share, by Type (Bacterial Skin Infections, Sexually Transmitted Infections, Foodborne Infections); Product (Consumables, Instruments); Technology (Isothermal Nucleic Acid Amplification Technology, Polymerase Chain Reaction, DNA Microarray, Immunodiagnostics); End-user (Hospitals, Labs, Research Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 5206
  • Published Date: Sep 01, 2023
  • Report Format: PDF, PPT

Companies Dominating the Bacterial Disease Diagnostics Landscape

top-features-companies
    • bioMérieux SA
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • F. Hoffmann-La Roche Ltd
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • DiaSorin SpA (Luminex)
    • Accelerate Diagnostics Inc.
    • Bruker Corp.
    • Danaher Corp.
    • Torus Biosystems
    • GENERI BIOTECH s.r.o.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • F. Hoffmann-La Roche Ltd. announced the collaboration with Janssen Biotech Inc. to expand its diagnosis portfolio for target therapies. It increases innovation and strengthens diagnostic technology.
     
  • bioMerieux launched the new CE-marking of VIDAS® KUBE™, it is a automated immunoassay system for VIDAS range. This will aid both clinical laboratories and the food industry to serve their customers rapidly.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5206
  • Published Date: Sep 01, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing cases of bacterial infection and technological advancement in diagnostic technology are the major factors driving the market growth.

The market size of bacterial disease diagnostics is anticipated to attain a CAGR of ~8% over the forecast period, i.e., 2023 – 2035.

The major players in the market are bioMérieux SA, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Becton, Dickinson and Company, DiaSorin SpA (Luminex), Accelerate Diagnostics Inc., Bruker Corp., Danaher Corp., Torus Biosystems, and GENERI BIOTECH s.r.o.

The bacterial skin infection segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying